ALNA Stock Alert: What to Know as Allena Pharmaceuticals Soars 200%
With hardly any warning, Allena Pharmaceuticals (NASDAQ: ALNA ) stock shot out of the gate this morning, tripling in price on heavy trading volume. Yet, there doesn’t appear to be any company-specific news surrounding Allena Pharmaceuticals. Could there be a massive short squeeze afoot? It’s a valid question, as traders on social media sites like Reddit have been known to target low-priced stocks. And shares of Allena Pharmaceuticals are super-cheap, even after today’s 200%-plus move. Besides, Reddit traders sometimes like to focus on under-the-radar companies, and Allena Pharmaceuticals is definitely under the radar, with its sub-$50 million market capitalization. Before you go chasing the ALNA stock rally, it’s important to know what the company is all about. Tiny but ambitious Allena Pharmaceuticals focuses on addressing hard-to-treat metabolic disorders by leveraging the power of oral enzymes. The company’s flagship product candidate is ALLN-346 , an orally administered enzyme that breaks down urate in the gastrointestinal tract.
ALNA Stock Alert: What to Know as Allena Pharmaceuticals Soars 200%
With hardly any warning, Allena Pharmaceuticals (NASDAQ: ALNA ) stock shot out of the gate this morning, tripling in price on heavy trading volume. Yet, there doesn’t appear to be any company-specific news surrounding Allena Pharmaceuticals. Could there be a massive short squeeze afoot? It’s a valid question, as traders on social media sites like Reddit have been known to target low-priced stocks. And shares of Allena Pharmaceuticals are super-cheap, even after today’s 200%-plus move. Besides, Reddit traders sometimes like to focus on under-the-radar companies, and Allena Pharmaceuticals is definitely under the radar, with its sub-$50 million market capitalization. Before you go chasing the ALNA stock rally, it’s important to know what the company is all about. Tiny but ambitious Allena Pharmaceuticals focuses on addressing hard-to-treat metabolic disorders by leveraging the power of oral enzymes. The company’s flagship product candidate is ALLN-346 , an orally administered enzyme that breaks down urate in the gastrointestinal tract.